Compare OVID & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | RGR |
|---|---|---|
| Founded | 2014 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 617.8M |
| IPO Year | 2017 | 1994 |
| Metric | OVID | RGR |
|---|---|---|
| Price | $2.74 | $38.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $4.60 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 3.4M | 135.8K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $7,252,000.00 | ★ $546,057,000.00 |
| Revenue This Year | N/A | $2.38 |
| Revenue Next Year | $19.34 | N/A |
| P/E Ratio | ★ N/A | $3,785.00 |
| Revenue Growth | ★ 1181.27 | 1.94 |
| 52 Week Low | $0.36 | $28.33 |
| 52 Week High | $3.11 | $48.21 |
| Indicator | OVID | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 60.23 | 43.95 |
| Support Level | $2.23 | $36.49 |
| Resistance Level | $3.05 | $38.89 |
| Average True Range (ATR) | 0.19 | 1.16 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 86.05 | 23.72 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.